The magnitude of nocebo effects in pain: A meta-analysis

ABSTRACT The investigation of nocebo effects is evolving, and a few literature reviews have emerged, although so far without quantifying such effects. This meta‐analysis investigated nocebo effects in pain. We searched the databases PubMed, EMBASE, Scopus, and the Cochrane Controlled Trial Register with the term “nocebo.” Only studies that investigated nocebo effects as the effects that followed the administration of an inert treatment along with verbal suggestions of symptom worsening and that included a no‐treatment control condition were eligible. Ten studies fulfilled the selection criteria. The effect sizes were calculated using Cohen's d and Hedges' g. The overall magnitude of the nocebo effect was moderate to large (lowest g = 0.62 [0.24–1.01] and highest g = 1.03 [0.63–1.43]) and highly variable (range of g = −0.43 to 4.05). The magnitudes and range of effect sizes was similar to those of placebo effects (d = 0.81) in mechanistic studies. In studies in which nocebo effects were induced by a combination of verbal suggestions and conditioning, the effect size was larger (lowest g = 0.76 [0.39–1.14] and highest g = 1.17 [0.52–1.81]) than in studies in which nocebo effects were induced by verbal suggestions alone (lowest g = 0.64 [−0.25 to 1.53] and highest g = 0.87 [0.40–1.34]). These findings are similar to those in the placebo literature. As the magnitude of the nocebo effect is variable and sometimes large, this meta‐analysis demonstrates the importance of minimizing nocebo effects in clinical practice.

[1]  F. Benedetti,et al.  The role of learning in nocebo and placebo effects , 2008, PAIN.

[2]  B. Rosen,et al.  A Functional Magnetic Resonance Imaging Study on the Neural Mechanisms of Hyperalgesic Nocebo Effect , 2008, The Journal of Neuroscience.

[3]  J. Riley,et al.  Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007 , 2009, PAIN®.

[4]  Wendy R. Sanhai,et al.  Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION , 2011, PAIN.

[5]  L. Hedges,et al.  Introduction to Meta‐Analysis , 2009, International Coaching Psychology Review.

[6]  F. Benedetti,et al.  Preventing motor training through nocebo suggestions , 2012, European Journal of Applied Physiology.

[7]  J. Riley,et al.  Reliable differences in placebo effects between clinical analgesic trials and studies of placebo analgesia mechanisms , 2003, Pain.

[8]  H. Fields,et al.  Pain--mechanics and management. , 1984, The Western journal of medicine.

[9]  J. Riley,et al.  A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia , 2002, Pain.

[10]  L. Colloca,et al.  The Nocebo Effect and Its Relevance for Clinical Practice , 2011, Psychosomatic medicine.

[11]  L. Hedges Estimation of effect size from a series of independent experiments. , 1982 .

[12]  L. Manchikanti,et al.  The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. , 2005, Pain physician.

[13]  P. Kissel,et al.  Placebos et Effet Placebo en Medecine , 1965 .

[14]  P. Enck,et al.  Gender and the nocebo response following conditioning and expectancy. , 2009, Journal of psychosomatic research.

[15]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[16]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[17]  M. Drici,et al.  Influence of the behaviour pattern on the nocebo response of healthy volunteers. , 1995, British journal of clinical pharmacology.

[18]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[19]  S. Elsenbruch,et al.  How positive and negative expectations shape the experience of visceral pain: an experimental pilot study in healthy women , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[20]  Sharon R. Weeks,et al.  Placebo effects: Understanding the mechanisms in health and disease, Fabrizio Benedetti. Oxford University Press (2009), ISBN: -13: 978-0-19-955912-1, 310 pages, $59.95 , 2009 .

[21]  A. Hrõbjartsson The uncontrollable placebo effect , 1996, European Journal of Clinical Pharmacology.

[22]  H. Beecher,et al.  The powerful placebo. , 1955, Journal of the American Medical Association.

[23]  R. Hahn,et al.  The nocebo phenomenon: concept, evidence, and implications for public health. , 1997, Preventive medicine.

[24]  A. Hrõbjartsson,et al.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.

[25]  Placebo/Nocebo Symptom Reporting in a Sham Herbal Supplement Trial , 2006, Evaluation & the health professions.

[26]  F. Benedetti,et al.  Nocebo hyperalgesia: how anxiety is turned into pain , 2007, Current opinion in anaesthesiology.

[27]  F. Benedetti Mechanisms of placebo and placebo-related effects across diseases and treatments. , 2008 .

[28]  Fabrizio Benedetti,et al.  Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide , 1997, Pain.

[29]  C. Pancaro,et al.  Nocebo-Induced Hyperalgesia During Local Anesthetic Injection , 2010, Anesthesia and analgesia.

[30]  Alfons Schnitzler,et al.  Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation , 2013, Behavioural Brain Research.

[31]  K. Wiech,et al.  The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil , 2011, Science Translational Medicine.

[32]  W. Kennedy The nocebo reaction. , 1961, Medical world.

[33]  P. Vernia,et al.  Diagnosis of lactose intolerance and the "nocebo" effect: the role of negative expectations. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[34]  赵红彬 Placebo , 2007 .

[35]  F. Benedetti,et al.  Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses , 2003, The Journal of Neuroscience.

[36]  Luana Colloca,et al.  Overt versus covert treatment for pain, anxiety, and Parkinson's disease , 2004, The Lancet Neurology.

[37]  D. Coleman,et al.  Positive and negative placebo effects resulting from the deceptive administration of an ergogenic aid. , 2007, International journal of sport nutrition and exercise metabolism.

[38]  D. Price,et al.  The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients An empirical investigation , 2003, Pain.

[39]  E. Bruera,et al.  Placebo and nocebo effects in randomized double‐blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer , 2010, Cancer.

[40]  Michael Hauck,et al.  Cortical correlates of false expectations during pain intensity judgments—a possible manifestation of placebo/nocebo cognitions , 2005, Brain, Behavior, and Immunity.

[41]  M. Amanzio Do we need a new procedure for the assessment of adverse events in anti-migraine clinical trials? , 2011, Recent patents on CNS drug discovery.

[42]  P. Petrovic,et al.  How the number of learning trials affects placebo and nocebo responses , 2010, PAIN®.

[43]  H. Fields,et al.  Pain: Mechanisms and Management , 1989 .

[44]  Fabrizio Benedetti,et al.  A comprehensive review of the placebo effect: recent advances and current thought. , 2008, Annual review of psychology.

[45]  B. Kröner-Herwig,et al.  Nocebo hyperalgesia induced by social observational learning , 2013, PAIN®.

[46]  G. Canonica,et al.  The nocebo effect during oral challenge in subjects with adverse drug reactions. , 2008, European annals of allergy and clinical immunology.

[47]  W. G. Cochran The combination of estimates from different experiments. , 1954 .

[48]  A. Barsky,et al.  Nonspecific medication side effects and the nocebo phenomenon. , 2002, JAMA.

[49]  K. Wiech,et al.  The effect of treatment history on therapeutic outcome: an experimental approach. , 2013, JAMA internal medicine.

[50]  F. Kraaimaat,et al.  Induction of nocebo and placebo effects on itch and pain by verbal suggestions , 2011, PAIN®.

[51]  M. Flaten,et al.  Expectations of increased and decreased pain explain the effect of conditioned pain modulation in females , 2012, Journal of pain research.

[52]  Fabrizio Benedetti,et al.  The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect , 2006, The Journal of Neuroscience.

[53]  A. Hrõbjartsson,et al.  Placebo interventions for all clinical conditions. , 2004, The Cochrane database of systematic reviews.

[54]  P. Lachenbruch Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[55]  P. Bąbel,et al.  The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning , 2013, PAIN®.

[56]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[57]  L. Hedges Distribution Theory for Glass's Estimator of Effect size and Related Estimators , 1981 .

[58]  M. Flaten,et al.  Drug-related information generates placebo and nocebo responses that modify the drug response. , 1999, Psychosomatic medicine.

[59]  Robert A Koeppe,et al.  Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. , 2008, Archives of general psychiatry.

[60]  R. Stern,et al.  The Effects of Manipulating Expectations Through Placebo and Nocebo Administration on Gastric Tachyarrhythmia and Motion-Induced Nausea , 2006, Psychosomatic medicine.

[61]  Feng Li,et al.  An Introduction to Metaanalysis , 2005 .

[62]  M. Flaten,et al.  Placebo and Nocebo Responses, Cortisol, and Circulating Beta-Endorphin , 2003, Psychosomatic medicine.

[63]  F. Benedetti,et al.  When words are painful: Unraveling the mechanisms of the nocebo effect , 2007, Neuroscience.

[64]  M. Ingvar,et al.  Nonconscious activation of placebo and nocebo pain responses , 2012, Proceedings of the National Academy of Sciences.

[65]  G. Oftedal,et al.  Nocebo as headache trigger: evidence from a sham‐controlled provocation study with RF fields , 2008, Acta neurologica Scandinavica. Supplementum.

[66]  G. Canonica,et al.  Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. , 2004, Journal of investigational allergology & clinical immunology.

[67]  Fabrizio Benedetti,et al.  A systematic review of adverse events in placebo groups of anti-migraine clinical trials , 2009, PAIN.